Expression profiling of Yersinia pestis during mouse pulmonary infection

Jonathan N Lawson1, C Rick Lyons, Stephen Albert Johnston

  • 1Center for Biomedical Inventions, The University of Texas-Southwestern Medical School, Dallas, Texas, USA.

DNA and Cell Biology
|November 30, 2006
PubMed

Insights

Yersinia pestis (plague) gene expression differs significantly between in vitro and in vivo pulmonary infection. Understanding these transcriptional changes in Yersinia pestis can guide the development of new plague vaccines and therapeutics.

Area of Science:

  • Microbiology
  • Pathogen Transcriptomics
  • Infectious Disease Research

Background:

  • Yersinia pestis causes plague via flea bite or aerosol, with high mortality.
  • Pneumonic plague is a bioterrorism concern.
  • Understanding Y. pestis transcriptional changes during infection is crucial for developing countermeasures.

Purpose of the Study:

  • To investigate the transcriptional profile of Y. pestis during pulmonary infection in a mouse model.
  • To compare in vivo gene expression with in vitro conditions simulating host transition.

Main Methods:

  • Development of a Y. pestis long oligonucleotide microarray.
  • In vitro analysis of Y. pestis gene expression at 27°C vs. 37°C.
  • In vivo analysis of Y. pestis gene expression in mouse lungs post-intranasal challenge (days 1-3).

Main Results:

  • Significant differences observed in Y. pestis transcriptional profiles between in vitro and in vivo conditions.
  • Y. pestis upregulates specific genes in response to the host lung environment.
  • Upregulated genes in genomic regions with altered %GC content were identified.

Conclusions:

  • Y. pestis exhibits distinct transcriptional responses to the mammalian host environment.
  • Genomic regions with altered %GC content may represent promising targets for plague vaccines and therapeutics.